Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Amedisys Inc Issues Q1 2013 Guidance Below Analysts' Estimates


Thursday, 25 Apr 2013 07:01am EDT 

Amedisys Inc announced that it anticipates first quarter 2013 revenue of approximately $339 million and net income from continuing operations attributable to Amedisys, Inc. per diluted share (EPS) between $0.08 and $0.10. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $361 million and EPS of $0.19 for the first quarter of 2013. 

Company Quote

15.86
0.14 +0.89%
22 Jul 2014